IGM Biosciences, Inc. Other Accrued Liabilities, Current
IGM Biosciences, Inc. had Other Accrued Liabilities, Current of $404.00 thousand as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2025-07-31
- 2025-06-30: Other Accrued Liabilities, Current $404.00K.
- 2025-03-31: Other Accrued Liabilities, Current $416.00K.
- 2024-12-31: Other Accrued Liabilities, Current $252.00K.
- 2024-09-30: Other Accrued Liabilities, Current $859.00K.
| Period end | Other Accrued Liabilities, Current |
|---|---|
| 2025-06-30 | $404.00K 10-Q · filed 2025-07-31 |
| 2025-03-31 | $416.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $252.00K 10-Q · filed 2025-07-31 |
| 2024-09-30 | $859.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.09M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $642.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $245.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $756.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $907.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $363.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $195.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $681.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $852.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $413.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $280.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $515.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $216.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $67.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $52.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $54.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $9.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $9.00K 10-K · filed 2021-03-30 |
| 2019-09-30 | $161.00K 10-Q · filed 2019-11-07 |
| 2018-12-31 | $447.00K 10-K · filed 2020-03-26 |